Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Dermata Therapeutics Inc.

    NASDAQ: DRMAW · Real-Time Price · USD
    0.02
    0.00 (29.03%)
    At close: Jun 09, 2025, 3:06 PM

    Dermata Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 3.16M 7.44M 6.24M 10.8M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 n/a n/a n/a 55.72K
    Receivables
    		 n/a 8.36K 12.6K n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 n/a 14.5K n/a 55.72K
    Total Current Assets
    		 3.53M 7.98M 6.94M 11.62M
    Property-Plant & Equipment
    		 n/a n/a n/a n/a
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 n/a n/a n/a 55.72K
    Total Assets
    		 3.53M 7.98M 6.94M 11.62M
    Account Payables
    		 808.01K 866.03K 496.7K 515.25K
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a n/a n/a
    Other Current Liabilities
    		 731.63K 716.49K n/a 0.00
    Total Current Liabilities
    		 1.97M 1.62M 922.63K 1.52M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 1.16B n/a n/a n/a
    Total Long-Term Liabilities
    		 1.16B n/a 496.7K n/a
    Total Liabilities
    		 1.97M 1.62M 922.63K 1.52M
    Total Debt
    		 n/a n/a n/a n/a
    Book Value
    		 n/a n/a n/a n/a
    Book Value Per Share
    		 n/a n/a n/a n/a
    Common Stock
    		 252.00 393.00 1.23K 833.00
    Retained Earnings
    		 -65.68M -53.39M -45.59M -35.98M
    Comprehensive Income
    		 n/a n/a n/a n/a
    Shareholders Equity
    		 1.56B 6.36M 6.02M 10.11M
    Total Investments
    		 3.16B n/a n/a n/a

    Add to Watchlist